Nitric oxide mediates the inhibition by interleukin-1 beta of pentagastrin-stimulated rat gastric acid secretion

Br J Pharmacol. 1993 Jan;108(1):9-10. doi: 10.1111/j.1476-5381.1993.tb13431.x.

Abstract

Bolus injection of interleukin-1 beta (2 micrograms kg-1, i.v.) inhibited acid secretion induced by intravenous infusion of pentagastrin (8 micrograms kg-1 h-1) in the continuously perfused stomach of the anaesthetized rat. Administration of interleukin-1 beta did not modify mean systemic arterial blood pressure. Pretreatment with NG-nitro-L-arginine methyl ester (L-NAME, 2-10 mg kg-1, i.v.), but not dexamethasone (5 mg kg-1, s.c. twice over 16 h), restored the acid secretory responses to pentagastrin. The actions of L-NAME were reversed by the prior administration of L-arginine (100 mg kg-1, i.v.), but not by its enantiomer D-arginine (100 mg kg-1, i.v.). L-NAME (5 mg kg-1, i.v.) increased blood pressure but this was not the mechanism by which interleukin-induced acid inhibition was prevented, since similar systemic pressor responses induced by phenylephrine (10 micrograms kg-1 min-1, i.v.), had no such effect. These findings suggest that interleukin-induced inhibition of acid responses to pentagastrin involves synthesis of NO from L-arginine.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Arginine / analogs & derivatives
  • Arginine / pharmacology
  • Blood Pressure / drug effects
  • Female
  • Gastric Acid / metabolism*
  • Infusions, Intravenous
  • Interleukin-1 / pharmacology*
  • Male
  • NG-Nitroarginine Methyl Ester
  • Nitric Oxide / metabolism*
  • Pentagastrin / administration & dosage
  • Pentagastrin / pharmacology*
  • Rats
  • Rats, Wistar
  • Stereoisomerism

Substances

  • Interleukin-1
  • Nitric Oxide
  • Arginine
  • Pentagastrin
  • NG-Nitroarginine Methyl Ester